Literature DB >> 10686504

Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases.

H Yssel1, H Groux.   

Abstract

Allergic asthma is a complex and heterogeneous disease which is characterized by intermittent reversible airway obstruction, chronic inflammation of the airways, bronchial hyperreactivity and an infiltration of lymphocytes and eosinophils into the airway submucosa. Animal models and clinical studies in humans have indicated an important role for T helper type 2 lymphocytes, producing IL-4, IL-5 and IL-13, in the pathogenesis of this disorder. However, although IL-4 and IL-13 have strong anti-inflammatory properties, the physiologic anti-inflammatory Th2 response does not seem to be operational in allergic asthma. Moreover, the induction of a Th1 response seems to aggravate, rather than ameliorate, its inflammatory character. This article will focus on the involvement of T lymphocyte subpopulations in the pathogenesis of allergic asthma and allergic diseases. In addition, a potential role of the subpopulation(s) of T regulatory cells in the induction and/or maintaince of the disease process will be discussed. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686504     DOI: 10.1159/000024292

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  25 in total

1.  TCR usage and cytokine expression in peripheral blood and BAL T cells.

Authors:  P Bakakos; C Pickard; J L Smith; A J Frew
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  Serum interleukins 6 and 8 in mild and severe asthmatic patients, is it difference?

Authors:  Javad Ghaffari; Ali Reza Rafiei; Abolghasem Ajami; Mohammadreza Mahdavi; Bahareh Hoshiar
Journal:  Caspian J Intern Med       Date:  2011

3.  Expression and functional analysis of toll-like receptors of peripheral blood cells in asthmatic patients: implication for immunopathological mechanism in asthma.

Authors:  Samantha W M Lun; C K Wong; Fanny W S Ko; David S C Hui; Christopher W K Lam
Journal:  J Clin Immunol       Date:  2008-12-06       Impact factor: 8.317

4.  The Effect of Cigarette Smoke-derived Oxidants on the Inflammatory Response of the Lung.

Authors:  Robert Foronjy; Jeanine D'Armiento
Journal:  Clin Appl Immunol Rev       Date:  2006-01-01

5.  Mucosal pathophysiology and inflammatory changes in the late phase of the intestinal allergic reaction in the rat.

Authors:  P C Yang; M C Berin; L Yu; M H Perdue
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 6.  T-cell subsets in the pathogenesis of human asthma.

Authors:  Flurina Meiler; Maya Zimmermann; Kurt Blaser; Cezmi A Akdis; Mübeccel Akdis
Journal:  Curr Allergy Asthma Rep       Date:  2006-03       Impact factor: 4.806

7.  Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma.

Authors:  C K Wong; C Y Ho; F W Ko; C H Chan; A S Ho; D S Hui; C W Lam
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

8.  Different regulation of T helper 1- and T helper 2-promoting cytokine signalling factors in human dendritic cells after exposure to protein versus contact allergens.

Authors:  Ingo Böttcher; Iris Bellinghausen; Bettina König; Jürgen Knop; Joachim Saloga
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

9.  Increase in Ksp37-positive peripheral blood lymphocytes in mild extrinsic asthma.

Authors:  M Kuepper; K Koester; K Bratke; D Myrtek; K Ogawa; K Nagata; J C Virchow; W Luttmann
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

10.  Increase in granzyme B+ lymphocytes and soluble granzyme B in bronchoalveolar lavage of allergen challenged patients with atopic asthma.

Authors:  K Bratke; B Böttcher; K Leeder; S Schmidt; M Küpper; J C Virchow; W Luttmann
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.